Global Small Interfering RNA (siRNA) Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Small Interfering RNA (siRNA) Drugs market size was valued at USD 1035.6 million in 2022 and is forecast to a readjusted size of USD 5308.7 million by 2029 with a CAGR of 26.3% during review period.
Small Interfering RNA (siRNA) drugs are a class of nucleic acid-based therapeutics that utilize short RNA molecules to silence or regulate the expression of specific genes. These drugs have the ability to interfere with the translation of messenger RNA (mRNA) into proteins, effectively 'silencing' the gene associated with that mRNA. SiRNA-based therapies have the potential to treat a variety of diseases, particularly those with a genetic or RNA-based component.
The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.
The Global Info Research report includes an overview of the development of the Small Interfering RNA (siRNA) Drugs industry chain, the market status of AHP (GIVLAARI, Onpattro), hATTR (GIVLAARI, Onpattro), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Small Interfering RNA (siRNA) Drugs.
Regionally, the report analyzes the Small Interfering RNA (siRNA) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Small Interfering RNA (siRNA) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Small Interfering RNA (siRNA) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Small Interfering RNA (siRNA) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., GIVLAARI, Onpattro).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Small Interfering RNA (siRNA) Drugs market.
Regional Analysis: The report involves examining the Small Interfering RNA (siRNA) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Small Interfering RNA (siRNA) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Small Interfering RNA (siRNA) Drugs:
Company Analysis: Report covers individual Small Interfering RNA (siRNA) Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Small Interfering RNA (siRNA) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (AHP, hATTR).
Technology Analysis: Report covers specific technologies relevant to Small Interfering RNA (siRNA) Drugs. It assesses the current state, advancements, and potential future developments in Small Interfering RNA (siRNA) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Small Interfering RNA (siRNA) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Small Interfering RNA (siRNA) Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Small Interfering RNA (siRNA) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Interfering RNA (siRNA) Drugs, with revenue, gross margin and global market share of Small Interfering RNA (siRNA) Drugs from 2018 to 2023.
Chapter 3, the Small Interfering RNA (siRNA) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Small Interfering RNA (siRNA) Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Interfering RNA (siRNA) Drugs.
Chapter 13, to describe Small Interfering RNA (siRNA) Drugs research findings and conclusion.
Small Interfering RNA (siRNA) drugs are a class of nucleic acid-based therapeutics that utilize short RNA molecules to silence or regulate the expression of specific genes. These drugs have the ability to interfere with the translation of messenger RNA (mRNA) into proteins, effectively 'silencing' the gene associated with that mRNA. SiRNA-based therapies have the potential to treat a variety of diseases, particularly those with a genetic or RNA-based component.
The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.
The Global Info Research report includes an overview of the development of the Small Interfering RNA (siRNA) Drugs industry chain, the market status of AHP (GIVLAARI, Onpattro), hATTR (GIVLAARI, Onpattro), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Small Interfering RNA (siRNA) Drugs.
Regionally, the report analyzes the Small Interfering RNA (siRNA) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Small Interfering RNA (siRNA) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Small Interfering RNA (siRNA) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Small Interfering RNA (siRNA) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., GIVLAARI, Onpattro).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Small Interfering RNA (siRNA) Drugs market.
Regional Analysis: The report involves examining the Small Interfering RNA (siRNA) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Small Interfering RNA (siRNA) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Small Interfering RNA (siRNA) Drugs:
Company Analysis: Report covers individual Small Interfering RNA (siRNA) Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Small Interfering RNA (siRNA) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (AHP, hATTR).
Technology Analysis: Report covers specific technologies relevant to Small Interfering RNA (siRNA) Drugs. It assesses the current state, advancements, and potential future developments in Small Interfering RNA (siRNA) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Small Interfering RNA (siRNA) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Small Interfering RNA (siRNA) Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- GIVLAARI
- Onpattro
- OXLUMO
- AMVUTTRA
- Leqvio
- AHP
- hATTR
- Other
- Alnylam
- Novartis
- Sylentis
- Arrowhead
- Silence Therapeutics
- Dicerna
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Small Interfering RNA (siRNA) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Interfering RNA (siRNA) Drugs, with revenue, gross margin and global market share of Small Interfering RNA (siRNA) Drugs from 2018 to 2023.
Chapter 3, the Small Interfering RNA (siRNA) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Small Interfering RNA (siRNA) Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Interfering RNA (siRNA) Drugs.
Chapter 13, to describe Small Interfering RNA (siRNA) Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Small Interfering RNA (siRNA) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Small Interfering RNA (siRNA) Drugs by Type
1.3.1 Overview: Global Small Interfering RNA (siRNA) Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type in 2022
1.3.3 GIVLAARI
1.3.4 Onpattro
1.3.5 OXLUMO
1.3.6 AMVUTTRA
1.3.7 Leqvio
1.4 Global Small Interfering RNA (siRNA) Drugs Market by Application
1.4.1 Overview: Global Small Interfering RNA (siRNA) Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 AHP
1.4.3 hATTR
1.4.4 Other
1.5 Global Small Interfering RNA (siRNA) Drugs Market Size & Forecast
1.6 Global Small Interfering RNA (siRNA) Drugs Market Size and Forecast by Region
1.6.1 Global Small Interfering RNA (siRNA) Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Small Interfering RNA (siRNA) Drugs Market Size by Region, (2018-2029)
1.6.3 North America Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alnylam
2.1.1 Alnylam Details
2.1.2 Alnylam Major Business
2.1.3 Alnylam Small Interfering RNA (siRNA) Drugs Product and Solutions
2.1.4 Alnylam Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alnylam Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Small Interfering RNA (siRNA) Drugs Product and Solutions
2.2.4 Novartis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Sylentis
2.3.1 Sylentis Details
2.3.2 Sylentis Major Business
2.3.3 Sylentis Small Interfering RNA (siRNA) Drugs Product and Solutions
2.3.4 Sylentis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sylentis Recent Developments and Future Plans
2.4 Arrowhead
2.4.1 Arrowhead Details
2.4.2 Arrowhead Major Business
2.4.3 Arrowhead Small Interfering RNA (siRNA) Drugs Product and Solutions
2.4.4 Arrowhead Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Arrowhead Recent Developments and Future Plans
2.5 Silence Therapeutics
2.5.1 Silence Therapeutics Details
2.5.2 Silence Therapeutics Major Business
2.5.3 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product and Solutions
2.5.4 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Silence Therapeutics Recent Developments and Future Plans
2.6 Dicerna
2.6.1 Dicerna Details
2.6.2 Dicerna Major Business
2.6.3 Dicerna Small Interfering RNA (siRNA) Drugs Product and Solutions
2.6.4 Dicerna Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dicerna Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Small Interfering RNA (siRNA) Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Small Interfering RNA (siRNA) Drugs by Company Revenue
3.2.2 Top 3 Small Interfering RNA (siRNA) Drugs Players Market Share in 2022
3.2.3 Top 6 Small Interfering RNA (siRNA) Drugs Players Market Share in 2022
3.3 Small Interfering RNA (siRNA) Drugs Market: Overall Company Footprint Analysis
3.3.1 Small Interfering RNA (siRNA) Drugs Market: Region Footprint
3.3.2 Small Interfering RNA (siRNA) Drugs Market: Company Product Type Footprint
3.3.3 Small Interfering RNA (siRNA) Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Small Interfering RNA (siRNA) Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Small Interfering RNA (siRNA) Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Small Interfering RNA (siRNA) Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
6.2 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
6.3 North America Small Interfering RNA (siRNA) Drugs Market Size by Country
6.3.1 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
7.2 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
7.3 Europe Small Interfering RNA (siRNA) Drugs Market Size by Country
7.3.1 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.3 France Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size by Region
8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2018-2029)
8.3.2 China Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.5 India Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
9.2 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
9.3 South America Small Interfering RNA (siRNA) Drugs Market Size by Country
9.3.1 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Country
10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Small Interfering RNA (siRNA) Drugs Market Drivers
11.2 Small Interfering RNA (siRNA) Drugs Market Restraints
11.3 Small Interfering RNA (siRNA) Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Small Interfering RNA (siRNA) Drugs Industry Chain
12.2 Small Interfering RNA (siRNA) Drugs Upstream Analysis
12.3 Small Interfering RNA (siRNA) Drugs Midstream Analysis
12.4 Small Interfering RNA (siRNA) Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Small Interfering RNA (siRNA) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Small Interfering RNA (siRNA) Drugs by Type
1.3.1 Overview: Global Small Interfering RNA (siRNA) Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type in 2022
1.3.3 GIVLAARI
1.3.4 Onpattro
1.3.5 OXLUMO
1.3.6 AMVUTTRA
1.3.7 Leqvio
1.4 Global Small Interfering RNA (siRNA) Drugs Market by Application
1.4.1 Overview: Global Small Interfering RNA (siRNA) Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 AHP
1.4.3 hATTR
1.4.4 Other
1.5 Global Small Interfering RNA (siRNA) Drugs Market Size & Forecast
1.6 Global Small Interfering RNA (siRNA) Drugs Market Size and Forecast by Region
1.6.1 Global Small Interfering RNA (siRNA) Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Small Interfering RNA (siRNA) Drugs Market Size by Region, (2018-2029)
1.6.3 North America Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Small Interfering RNA (siRNA) Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alnylam
2.1.1 Alnylam Details
2.1.2 Alnylam Major Business
2.1.3 Alnylam Small Interfering RNA (siRNA) Drugs Product and Solutions
2.1.4 Alnylam Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alnylam Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Small Interfering RNA (siRNA) Drugs Product and Solutions
2.2.4 Novartis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Sylentis
2.3.1 Sylentis Details
2.3.2 Sylentis Major Business
2.3.3 Sylentis Small Interfering RNA (siRNA) Drugs Product and Solutions
2.3.4 Sylentis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sylentis Recent Developments and Future Plans
2.4 Arrowhead
2.4.1 Arrowhead Details
2.4.2 Arrowhead Major Business
2.4.3 Arrowhead Small Interfering RNA (siRNA) Drugs Product and Solutions
2.4.4 Arrowhead Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Arrowhead Recent Developments and Future Plans
2.5 Silence Therapeutics
2.5.1 Silence Therapeutics Details
2.5.2 Silence Therapeutics Major Business
2.5.3 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product and Solutions
2.5.4 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Silence Therapeutics Recent Developments and Future Plans
2.6 Dicerna
2.6.1 Dicerna Details
2.6.2 Dicerna Major Business
2.6.3 Dicerna Small Interfering RNA (siRNA) Drugs Product and Solutions
2.6.4 Dicerna Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dicerna Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Small Interfering RNA (siRNA) Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Small Interfering RNA (siRNA) Drugs by Company Revenue
3.2.2 Top 3 Small Interfering RNA (siRNA) Drugs Players Market Share in 2022
3.2.3 Top 6 Small Interfering RNA (siRNA) Drugs Players Market Share in 2022
3.3 Small Interfering RNA (siRNA) Drugs Market: Overall Company Footprint Analysis
3.3.1 Small Interfering RNA (siRNA) Drugs Market: Region Footprint
3.3.2 Small Interfering RNA (siRNA) Drugs Market: Company Product Type Footprint
3.3.3 Small Interfering RNA (siRNA) Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Small Interfering RNA (siRNA) Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Small Interfering RNA (siRNA) Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Small Interfering RNA (siRNA) Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
6.2 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
6.3 North America Small Interfering RNA (siRNA) Drugs Market Size by Country
6.3.1 North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
7.2 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
7.3 Europe Small Interfering RNA (siRNA) Drugs Market Size by Country
7.3.1 Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.3 France Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Small Interfering RNA (siRNA) Drugs Market Size by Region
8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2018-2029)
8.3.2 China Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.5 India Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
9.2 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
9.3 South America Small Interfering RNA (siRNA) Drugs Market Size by Country
9.3.1 South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Country
10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Small Interfering RNA (siRNA) Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Small Interfering RNA (siRNA) Drugs Market Drivers
11.2 Small Interfering RNA (siRNA) Drugs Market Restraints
11.3 Small Interfering RNA (siRNA) Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Small Interfering RNA (siRNA) Drugs Industry Chain
12.2 Small Interfering RNA (siRNA) Drugs Upstream Analysis
12.3 Small Interfering RNA (siRNA) Drugs Midstream Analysis
12.4 Small Interfering RNA (siRNA) Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alnylam Company Information, Head Office, and Major Competitors
Table 6. Alnylam Major Business
Table 7. Alnylam Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 8. Alnylam Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alnylam Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 13. Novartis Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Sylentis Company Information, Head Office, and Major Competitors
Table 16. Sylentis Major Business
Table 17. Sylentis Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 18. Sylentis Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Sylentis Recent Developments and Future Plans
Table 20. Arrowhead Company Information, Head Office, and Major Competitors
Table 21. Arrowhead Major Business
Table 22. Arrowhead Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 23. Arrowhead Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Arrowhead Recent Developments and Future Plans
Table 25. Silence Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Silence Therapeutics Major Business
Table 27. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 28. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Silence Therapeutics Recent Developments and Future Plans
Table 30. Dicerna Company Information, Head Office, and Major Competitors
Table 31. Dicerna Major Business
Table 32. Dicerna Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 33. Dicerna Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Dicerna Recent Developments and Future Plans
Table 35. Global Small Interfering RNA (siRNA) Drugs Revenue (USD Million) by Players (2018-2023)
Table 36. Global Small Interfering RNA (siRNA) Drugs Revenue Share by Players (2018-2023)
Table 37. Breakdown of Small Interfering RNA (siRNA) Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Small Interfering RNA (siRNA) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key Small Interfering RNA (siRNA) Drugs Players
Table 40. Small Interfering RNA (siRNA) Drugs Market: Company Product Type Footprint
Table 41. Small Interfering RNA (siRNA) Drugs Market: Company Product Application Footprint
Table 42. Small Interfering RNA (siRNA) Drugs New Market Entrants and Barriers to Market Entry
Table 43. Small Interfering RNA (siRNA) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Small Interfering RNA (siRNA) Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Type (2018-2023)
Table 46. Global Small Interfering RNA (siRNA) Drugs Consumption Value Forecast by Type (2024-2029)
Table 47. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023)
Table 48. Global Small Interfering RNA (siRNA) Drugs Consumption Value Forecast by Application (2024-2029)
Table 49. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 79. Small Interfering RNA (siRNA) Drugs Raw Material
Table 80. Key Suppliers of Small Interfering RNA (siRNA) Drugs Raw Materials
Table 1. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alnylam Company Information, Head Office, and Major Competitors
Table 6. Alnylam Major Business
Table 7. Alnylam Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 8. Alnylam Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alnylam Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 13. Novartis Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Sylentis Company Information, Head Office, and Major Competitors
Table 16. Sylentis Major Business
Table 17. Sylentis Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 18. Sylentis Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Sylentis Recent Developments and Future Plans
Table 20. Arrowhead Company Information, Head Office, and Major Competitors
Table 21. Arrowhead Major Business
Table 22. Arrowhead Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 23. Arrowhead Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Arrowhead Recent Developments and Future Plans
Table 25. Silence Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Silence Therapeutics Major Business
Table 27. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 28. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Silence Therapeutics Recent Developments and Future Plans
Table 30. Dicerna Company Information, Head Office, and Major Competitors
Table 31. Dicerna Major Business
Table 32. Dicerna Small Interfering RNA (siRNA) Drugs Product and Solutions
Table 33. Dicerna Small Interfering RNA (siRNA) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Dicerna Recent Developments and Future Plans
Table 35. Global Small Interfering RNA (siRNA) Drugs Revenue (USD Million) by Players (2018-2023)
Table 36. Global Small Interfering RNA (siRNA) Drugs Revenue Share by Players (2018-2023)
Table 37. Breakdown of Small Interfering RNA (siRNA) Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Small Interfering RNA (siRNA) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key Small Interfering RNA (siRNA) Drugs Players
Table 40. Small Interfering RNA (siRNA) Drugs Market: Company Product Type Footprint
Table 41. Small Interfering RNA (siRNA) Drugs Market: Company Product Application Footprint
Table 42. Small Interfering RNA (siRNA) Drugs New Market Entrants and Barriers to Market Entry
Table 43. Small Interfering RNA (siRNA) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Small Interfering RNA (siRNA) Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Type (2018-2023)
Table 46. Global Small Interfering RNA (siRNA) Drugs Consumption Value Forecast by Type (2024-2029)
Table 47. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023)
Table 48. Global Small Interfering RNA (siRNA) Drugs Consumption Value Forecast by Application (2024-2029)
Table 49. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa Small Interfering RNA (siRNA) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 79. Small Interfering RNA (siRNA) Drugs Raw Material
Table 80. Key Suppliers of Small Interfering RNA (siRNA) Drugs Raw Materials
LIST OF FIGURES
Figure 1. Small Interfering RNA (siRNA) Drugs Picture
Figure 2. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type in 2022
Figure 4. GIVLAARI
Figure 5. Onpattro
Figure 6. OXLUMO
Figure 7. AMVUTTRA
Figure 8. Leqvio
Figure 9. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application in 2022
Figure 11. AHP Picture
Figure 12. hATTR Picture
Figure 13. Other Picture
Figure 14. Global Small Interfering RNA (siRNA) Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Small Interfering RNA (siRNA) Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Small Interfering RNA (siRNA) Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region in 2022
Figure 19. North America Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Small Interfering RNA (siRNA) Drugs Revenue Share by Players in 2022
Figure 25. Small Interfering RNA (siRNA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Small Interfering RNA (siRNA) Drugs Market Share in 2022
Figure 27. Global Top 6 Players Small Interfering RNA (siRNA) Drugs Market Share in 2022
Figure 28. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Type (2018-2023)
Figure 29. Global Small Interfering RNA (siRNA) Drugs Market Share Forecast by Type (2024-2029)
Figure 30. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Application (2018-2023)
Figure 31. Global Small Interfering RNA (siRNA) Drugs Market Share Forecast by Application (2024-2029)
Figure 32. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. France Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 49. China Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. India Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. Small Interfering RNA (siRNA) Drugs Market Drivers
Figure 67. Small Interfering RNA (siRNA) Drugs Market Restraints
Figure 68. Small Interfering RNA (siRNA) Drugs Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Small Interfering RNA (siRNA) Drugs in 2022
Figure 71. Manufacturing Process Analysis of Small Interfering RNA (siRNA) Drugs
Figure 72. Small Interfering RNA (siRNA) Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Small Interfering RNA (siRNA) Drugs Picture
Figure 2. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type in 2022
Figure 4. GIVLAARI
Figure 5. Onpattro
Figure 6. OXLUMO
Figure 7. AMVUTTRA
Figure 8. Leqvio
Figure 9. Global Small Interfering RNA (siRNA) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application in 2022
Figure 11. AHP Picture
Figure 12. hATTR Picture
Figure 13. Other Picture
Figure 14. Global Small Interfering RNA (siRNA) Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Small Interfering RNA (siRNA) Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Small Interfering RNA (siRNA) Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region in 2022
Figure 19. North America Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Small Interfering RNA (siRNA) Drugs Revenue Share by Players in 2022
Figure 25. Small Interfering RNA (siRNA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Small Interfering RNA (siRNA) Drugs Market Share in 2022
Figure 27. Global Top 6 Players Small Interfering RNA (siRNA) Drugs Market Share in 2022
Figure 28. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Type (2018-2023)
Figure 29. Global Small Interfering RNA (siRNA) Drugs Market Share Forecast by Type (2024-2029)
Figure 30. Global Small Interfering RNA (siRNA) Drugs Consumption Value Share by Application (2018-2023)
Figure 31. Global Small Interfering RNA (siRNA) Drugs Market Share Forecast by Application (2024-2029)
Figure 32. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. France Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 49. China Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. India Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Small Interfering RNA (siRNA) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Small Interfering RNA (siRNA) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. Small Interfering RNA (siRNA) Drugs Market Drivers
Figure 67. Small Interfering RNA (siRNA) Drugs Market Restraints
Figure 68. Small Interfering RNA (siRNA) Drugs Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Small Interfering RNA (siRNA) Drugs in 2022
Figure 71. Manufacturing Process Analysis of Small Interfering RNA (siRNA) Drugs
Figure 72. Small Interfering RNA (siRNA) Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
